Thailand’s National Communicable Disease Committee has approved new measures to control influenza, dengue, Mpox, and ...

Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral ...

The Power of a Single Spark,” on Saturday in Cohen Auditorium. The event featured eight talks given by current Tufts students ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

HEV-specific antiviral treatment is still lacking ... Effectiveness of the hepatitis E vaccine HEV 239 amongst high-risk groups isn’t well studied. Here, Zhuang et al. analyse a decade of ...

The most common type of viral hepatitis is caused by the hepatitis A virus. HEV-specific antiviral treatment is still lacking. Here, the authors functionally and structurally characterize broadly ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...

This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

AstraZeneca's Imfinzi (durvalumab) plus chemotherapy combo has received the European Medicines Agency’s (EMA) Committee for ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...